G2M | Next Generation IVD solutions for Genomics vs Xagenic

G2M | Next Generation IVD solutions for Genomics logo

G2M | Next Generation IVD solutions for Genomics

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions

103 employees · est. 2016 · Gurgaon, India

VS
Xagenic logo

Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduced healthcare costs

est. 2010

Xagenic is the older company (2016 vs 2010).

Side-by-Side Comparison

G2M | Next Generation IVD solutions for Genomics Xagenic
Founded
2016 2010 older
Headquarters
Gurgaon, India Not tracked yet
Employees
103 Not tracked yet
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Medical Devices
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $63.28M
Funding Rounds
Not tracked yet 7
Services
Molecular Testing Workflows, Next-Generation Sequencing (NGS) Panels, RT-PCR Diagnostic Kits, Point-of-Care Solutions, Nucleic Acid Extraction Systems Not tracked yet
Target Customers
Clinical Laboratories, Research Settings, Healthcare Providers, Diagnostic Centers Not tracked yet
Taxonomy
Molecular DiagnosticsIVD SolutionsNGS Clinical PanelsPOC Testing SolutionsRT-PCR KitsRapid Testing Kits +9 Molecular DiagnosticsRapid TestingPoint-of-careInfectious DiseaseClinical SamplesDecentralized Testing +3
Website
genes2me.com xagenic.com
G2M | Next Generation IVD solutions for Genomics logo

About G2M | Next Generation IVD solutions for Genomics

Genes2Me, founded in 2016, stands at the forefront of India's Biotechnology arena, focusing on innovative In-Vitro Diagnostics (IVD) solutions tailored for Genomics. With its headquarters in India, the company operates at the intersection of Health Care and Health and Wellness, primarily in manufact...

Xagenic logo

About Xagenic

Xagenic, based in Toronto, Canada, is a trailblazer in molecular diagnostics, dedicated to developing cutting-edge technology for rapid, near-patient diagnostic testing. Their mission is to equip clinicians with the ability to make timely treatment decisions during the initial patient consultation,...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches G2M | Next Generation IVD solutions for Genomics and Xagenic for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when G2M | Next Generation IVD solutions for Genomics or Xagenic moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

G2M | Next Generation IVD solutions for Genomics was founded in 2016, based in Gurgaon, India, with 103 employees. Genes2Me, founded in 2016, stands at the forefront of India's Biotechnology arena, focusing on innovative In-Vitro Diagnostics (IVD) solutions tailored for Genomics. With its headquarters in India, th. Xagenic was founded in 2010. Xagenic, based in Toronto, Canada, is a trailblazer in molecular diagnostics, dedicated to developing cutting-edge technology for rapid, near-patient diagnostic testing. Their mission is to equip clin.
G2M | Next Generation IVD solutions for Genomics has raised no disclosed funding and Xagenic $63.28M. Latest stage: Xagenic Series B.
Both work in Biotechnology and Health Care and list molecular diagnostics among their focus areas.

Compare G2M | Next Generation IVD solutions for Genomics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at G2M | Next Generation IVD solutions for Genomics on 29 Mar 2026, and Xagenic on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes